Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve the Standalone Unaudited Financial ....
Awaiting price reaction for this filing.
Sarda Proteins Ltd has informed BSE that its Board of Directors will meet on 14th August 2025 to consider and approve the standalone unaudited financial results for the quarter ended 30th June 2025 (Q1 FY26). The filing is made under SEBI Listing Regulations, 2015. The trading window for dealing in the company's securities has been closed since 1st July 2025 and will remain closed until 48 hours after the results are declared. No financial figures or outcomes have been disclosed in this intimation.
This is a routine procedural filing ahead of the Q1 earnings announcement. Shareholders should watch for the actual results on or after 14th August 2025, which could trigger short-term price movement based on the numbers disclosed.